Franceschi S, Arniani S, Balzi D, Geddes M
Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano (PN), Italy.
Br J Cancer. 1996 Dec;74(11):1812-4. doi: 10.1038/bjc.1996.635.
In order to elucidate survival rates and risk of second primary cancer, we assessed 204 patients with histologically confirmed classic Kaposi's sarcoma (KS) who were identified in 11 Italian population-based cancer registries. One hundred and thirty-nine were men (median age 70 years) and 65 were women (median age 72). One, 5 and 10 year survival rates were 0.92, 0.69 and 0.46 respectively. Median survival was 9.4 years (i.e. not different from the Italian general population of the same sex and age). Survival did not vary according to sex and tumour site (i.e. lower limbs only or other). Eleven second primary cancers, including two lung and two kidney cancers, were reported after KS diagnosis (not different from the expected number).
为了阐明生存率和第二原发性癌症的风险，我们评估了204例经组织学确诊为经典型卡波西肉瘤（KS）的患者，这些患者来自11个意大利基于人群的癌症登记处。其中139例为男性（中位年龄70岁），65例为女性（中位年龄72岁）。1年、5年和10年生存率分别为0.92、0.69和0.46。中位生存期为9.4年（即与同性别和年龄的意大利普通人群无差异）。生存率不因性别和肿瘤部位（即仅下肢或其他部位）而有所不同。在KS诊断后报告了11例第二原发性癌症，包括2例肺癌和2例肾癌（与预期数量无差异）。
